Latest GATX Corp (GMT) Headlines Shares of GMT Up 24.6%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest GATX Corp (GMT) Headlines

Shares of GMT Up 24.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Mar 12, 9:39AM CDT
SmarTrend identified an Uptrend for GATX (NYSE:GMT) on December 23rd, 2013 at $51.56. In approximately 3 months, GATX has returned 24.60% as of today's recent price of $64.24.

Weakness Seen in FreightCar America (RAIL): Stock Tumbles 8.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:53AM CDT
FreightCar America's shares fell by over 8% on the day. This reverses the recent trend for RAIL as the stock is now up more than 3% in the past one-month time frame.

Roundtable Top Picks for the Week of Mar. 10th - Video Blog
Panel Of Zacks Experts - Zacks Investment Research - Mon Mar 10, 3:23PM CDT
Ideas for Aerospace, Semiconductors and Transportation. Opportunities covered include iShares US Aerospace & Defense ETF (ITA), NXP Semiconductors, NV (NXPI) and GATX Corp (GMT).

26.4% Return Seen to Date on SmarTrend GATX Call (GMT)
Comtex SmarTrend(R) - Wed Mar 05, 9:10AM CST
SmarTrend identified an Uptrend for GATX (NYSE:GMT) on December 23rd, 2013 at $51.56. In approximately 2 months, GATX has returned 26.39% as of today's recent price of $65.16.

GATX Up 22.0% Since SmarTrend Uptrend Call (GMT)
Comtex SmarTrend(R) - Tue Feb 25, 4:47PM CST
SmarTrend identified an Uptrend for GATX (NYSE:GMT) on December 23rd, 2013 at $51.56. In approximately 2 months, GATX has returned 22.01% as of today's recent price of $62.90.

GATX Corporation to Present at the Raymond James Institutional Investor Conference
Business Wire - Tue Feb 25, 3:25PM CST
GATX Corporation (NYSE:GMT) today announced that Brian A. Kenney, president and chief executive officer, will present at the Raymond James Institutional Investor Conference in Orlando, Florida on Wednesday, March 5, 2014. The presentation will include an overview of GATX's operations.

Uptrend Call Working As GATX Stock Rises 16.9% (GMT)
Comtex SmarTrend(R) - Tue Feb 18, 11:11AM CST
SmarTrend identified an Uptrend for GATX (NYSE:GMT) on December 23rd, 2013 at $51.56. In approximately 2 months, GATX has returned 16.88% as of today's recent price of $60.26.

Shares of GMT Up 10.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 10, 9:31AM CST
SmarTrend identified an Uptrend for GATX (NYSE:GMT) on December 23rd, 2013 at $51.56. In approximately 2 months, GATX has returned 10.29% as of today's recent price of $56.86.

Can GATX (GMT) Continue to Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 7:39AM CST
GATX has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy

Ryder Beats on Q4 Earnings, Grows YoY - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 04, 2:01PM CST
Ryder System Inc. reported fourth quarter 2013 adjusted earnings of $1.35 per share, surpassing the Zacks Consensus Estimate.

GATX Corporation to Present at Stifel Transportation and Logistics Conference
Business Wire - Tue Feb 04, 12:30PM CST
GATX Corporation (NYSE:GMT) today announced that Robert C. Lyons, executive vice president and chief financial officer, will present at the Stifel Transportation and Logistics Conference in Palm Beach, Florida on Tuesday, February 11, 2014. The presentation will include an overview of GATX's operations.

GATX Shares Up 12.3% Since SmarTrend's Buy Recommendation (GMT)
Comtex SmarTrend(R) - Fri Jan 31, 5:18PM CST
SmarTrend identified an Uptrend for GATX (NYSE:GMT) on December 23rd, 2013 at $51.56. In approximately 1 month, GATX has returned 12.31% as of today's recent price of $57.90.

Zacks Investment Ideas feature highlights: Logitech, GATX, Acuity Brands and Open Text
PR Newswire - Fri Jan 31, 8:30AM CST
Today, Zacks Investment Ideas feature highlights Features: Logitech (Nasdaq:LOGI-Free Report), GATX Corp (NYSE:GMT-Free Report), Acuity Brands (NYSE:AYI-Free Report) and Open Text Corp (Nasdaq:OTEX-Free Report).

4 Big Winners from Q4 Earnings Season - Investment Ideas
Todd Bunton - ZACKS - Thu Jan 30, 1:15PM CST
4 Big Winners from Q4 Earnings Season - Investment Ideas

GATX, Boingo Wireless, Abercrombie & Fitch, PepsiCoand Zalehighlighted as Zacks Bull and Bear of the Day
PR Newswire - Thu Jan 30, 8:30AM CST
Zacks Equity Research highlights GATX Corporation (NYSE:GMT-Free Report) as the Bull of the Day and Boingo Wireless (Nasdaq:WIFI-Free Report)as the Bear of the Day. In addition, Zacks Equity Research provides analysis onAbercrombie & Fitch Co. (NYSE:ANF-Free Report), PepsiCo Inc. (NYSEEP-Free Report) and Zale Corp. (NYSE:ZLC-Free Report).

Bull of the Day: GATX Corporation (GMT) - Bull of the Day
Todd Bunton - ZACKS - Thu Jan 30, 5:30AM CST
Bull of the Day: GATX Corporation (GMT) - Bull of the Day

GATX Corp. (GMT): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 7:59AM CST
One stock that might be an intriguing choice for investors right now is GATX Corp. (GMT). This is because this security in the Rental & Leasing Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

3 Unusual-Volume Stocks in Breakout Territory
at The Street - Tue Jan 28, 6:00AM CST
These stocks rising on unusual volume are within range of triggering breakout trades.

GATX Corp. (GMT) Stock Research Links

GMT Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 20

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 21

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading